Indian pharma sector to log 7-9% growth in FY26 despite US headwinds: ICRA
[ad_1] India’s pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook. According to ICRA, the growth momentum will be driven by 8-10 per cent expansion in the…